{"access":{"can_view":true,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":false,"can_get_doi":false,"can_share":true,"can_move":true,"can_move_outside":true,"can_transfer":true,"can_download":true,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"authors":[{"name":"Andriko Palmowski","affiliation":"Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Germany","affiliation_url":"http://www.charite.de/","username":"andriko-palmowski","link":"","image":{"source":"/img/avatars/009.png","placeholder":"/img/avatars/009.png","webp_source":""},"note":"","is_verified_user":true}],"before_start":"","book_chapter":null,"can_accept_authorship":false,"can_be_copied":true,"can_claim_authorship":false,"can_manage_keywords":true,"can_remove_fork":false,"can_sign":false,"child_steps":{},"cited_protocols":[],"collection_items":[],"created_on":1688371221,"creator":{"name":"Andriko Palmowski","affiliation":"Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Germany","affiliation_url":"http://www.charite.de/","username":"andriko-palmowski","link":"","image":{"source":"/img/avatars/009.png","placeholder":"/img/avatars/009.png","webp_source":""},"badges":[{"id":2,"name":"Author","image":{"source":"/img/badges/bronze.svg","placeholder":"/img/badges/bronze.svg"}}],"affiliations":[{"affiliation":"Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Germany","url":"http://www.charite.de/","is_default":true}]},"description":"{\"blocks\":[{\"key\":\"26eg1\",\"text\":\"Background\\nGlucocorticoids (GCs) are regularly used drugs in the treatment of rheumatoid arthritis (RA), and lower bone mineral density and fractures are common adverse effects of the treatment with higher GC dosages. However, the effects of low dose (i.e., ≤7.5mg/day) and very low dose (i.e., ≤5mg/day) treatment over longer periods of time (i.e., ≥ 24 months), as often seen in RA, have not been fully elucidated yet.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":11}],\"entityRanges\":[{\"key\":0,\"offset\":258,\"length\":1}],\"data\":{}},{\"key\":\"ep9c7\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2re02\",\"text\":\"Objective\\nTo conduct a systematic review and meta-analysis of individual patient data from long-term randomized controlled trials (RCTs) in RA, which compared low dose GCs to a control treatment, in order to investigate the effects on bone mineral density and incidence of fractures (clinical/symptomatic). \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":10}],\"entityRanges\":[],\"data\":{}},{\"key\":\"45i5p\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"bkfir\",\"text\":\"Methods \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":8}],\"entityRanges\":[],\"data\":{}},{\"key\":\"74tge\",\"text\":\"We will search the literature to identify published trials which collected data on bone mineral density and/or the incidence of fractures. This will be followed by the acquisition of individual participant data. Included RCTs will be combined to compare bone mineral density and fractures in GC and control groups. To underpin our findings, we will perform additional analyses to identify potential effect modifiers and a sensitivity analysis related to missing data. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"MUTABLE\",\"data\":{\"guid\":\"498D5BF4197911EEAFD80A58A9FEAC02\",\"url\":null}}}}","disclaimer":"","document":"","documents":[],"doi":"dx.doi.org/10.17504/protocols.io.6qpvr3ombvmk/v1","doi_status":1,"ethics_statement":null,"fork_id":null,"fork_info":null,"forks":[],"funders":[{"funder_name":"Elsbeth Bonhoff Stiftung","grant_id":"244"},{"funder_name":"The Oak Foundation","grant_id":"OCAY-18-774-OFIL"}],"groups":[],"guid":"A095D280197711EE84E687EF9A00704F","guidelines":"","has_references":false,"has_step_reagents":false,"has_versions":false,"id":84382,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"image_attribution":"","in_trash":false,"is_bookmarked":false,"is_contact_suspended":false,"is_content_confidential":false,"is_content_warning":false,"is_doi_reserved":true,"is_in_pending_publishing":false,"is_in_transfer":false,"is_owner":true,"is_research":true,"is_retracted":false,"is_shared_directly":false,"is_subprotocol":null,"is_unlisted":false,"item_id":1135727,"journal":null,"journals":[],"keywords":"","last_modified":1688372108,"link":"","location":null,"manuscript_citation":"","materials":[],"materials_text":"","ownership_history":null,"parent_collections":[],"parent_protocols":[],"peer_reviewed":false,"protocol_references":"","public":true,"public_fork_note":"","published_on":1688372108,"references":[],"related_equipments":[],"related_materials":[],"reserved_doi":"10.17504/protocols.io.6qpvr3ombvmk/v1","retraction_reason":null,"samples":{},"shared_access_id":0,"show_comparison":false,"sign_info":null,"state_version_id":47,"stats":{"is_voted":false,"number_of_views":16,"number_of_steps":1,"number_of_bookmarks":0,"number_of_comments":0,"number_of_bookmarked_comments":0,"number_of_steps_comments":0,"number_of_protocol_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"number_of_reagents":0,"number_of_equipments":0,"number_of_collections":0,"number_of_forks":{"private":0,"public":0},"number_of_accessible_forks":0},"status":{"id":3,"info":"This is a systematic reivew protocol."},"steps":[{"id":1725465,"guid":"DEE8DEB0197711EE84E687EF9A00704F","previous_id":0,"previous_guid":null,"section":"\u003cp\u003ePDF Protocol\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"fedg6\",\"text\":\"  \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"163r1\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"file\",\"mutability\":\"MUTABLE\",\"data\":{\"forceSelection\":true,\"guid\":\"03C583F0197811EE84E687EF9A00704F\",\"id\":386139,\"original_name\":\"Protocol.pdf\",\"placeholder\":\"\",\"raw_source\":\"\",\"source\":\"https://content.protocols.io/files/m3c53n36.pdf\"}}}}","data":null,"protocol_id":84382,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"1","cases":[],"critical":null}],"template_id":1,"title":"Changes in Bone Mineral Density and Incidence of Fractures during Two Years of Low Dose Glucocorticoid Treatment for Rheumatoid Arthritis: Protocol for a Systematic Review and Individual Participant Data Meta-Analysis","title_html":"Changes in Bone Mineral Density and Incidence of Fractures during Two Years of Low Dose Glucocorticoid Treatment for Rheumatoid Arthritis: Protocol for a Systematic Review and Individual Participant Data Meta-Analysis","type_id":1,"units":[{"id":1,"type_id":3,"name":"µL","can_manage":0,"read_only":0},{"id":2,"type_id":3,"name":"mL","can_manage":0,"read_only":0},{"id":3,"type_id":3,"name":"L","can_manage":0,"read_only":0},{"id":4,"type_id":3,"name":"µg","can_manage":0,"read_only":0},{"id":5,"type_id":3,"name":"mg","can_manage":0,"read_only":0},{"id":6,"type_id":3,"name":"g","can_manage":0,"read_only":0},{"id":7,"type_id":3,"name":"kg","can_manage":0,"read_only":0},{"id":8,"type_id":3,"name":"ng","can_manage":0,"read_only":0},{"id":9,"type_id":3,"name":"Hz","can_manage":0,"read_only":0},{"id":10,"type_id":24,"name":"°C","can_manage":0,"read_only":0},{"id":11,"type_id":24,"name":"°К","can_manage":0,"read_only":0},{"id":12,"type_id":24,"name":"°F","can_manage":0,"read_only":0},{"id":13,"type_id":25,"name":"Mass Percent","can_manage":0,"read_only":0},{"id":14,"type_id":25,"name":"% volume","can_manage":0,"read_only":0},{"id":15,"type_id":25,"name":"Mass / % volume","can_manage":0,"read_only":0},{"id":16,"type_id":25,"name":"Parts per Million (PPM)","can_manage":0,"read_only":0},{"id":17,"type_id":25,"name":"Parts per Billion (PPB)","can_manage":0,"read_only":0},{"id":18,"type_id":25,"name":"Parts per Trillion (PPT)","can_manage":0,"read_only":0},{"id":19,"type_id":25,"name":"Mole Fraction","can_manage":0,"read_only":0},{"id":20,"type_id":25,"name":"Mole Percent","can_manage":0,"read_only":0},{"id":21,"type_id":25,"name":"Molarity (M)","can_manage":0,"read_only":1},{"id":22,"type_id":25,"name":"Molarity (m)","can_manage":0,"read_only":0},{"id":23,"type_id":25,"name":"Genome copies per ml","can_manage":0,"read_only":0},{"id":24,"type_id":3,"name":"μV","can_manage":0,"read_only":0},{"id":25,"type_id":3,"name":"ms","can_manage":0,"read_only":0},{"id":26,"type_id":3,"name":"pg","can_manage":0,"read_only":0},{"id":27,"type_id":25,"name":"Molarity dilutions","can_manage":0,"read_only":0},{"id":28,"type_id":25,"name":"millimolar (mM)","can_manage":0,"read_only":0},{"id":29,"type_id":25,"name":"micromolar (µM)","can_manage":0,"read_only":0},{"id":30,"type_id":25,"name":"nanomolar (nM)","can_manage":0,"read_only":0},{"id":31,"type_id":25,"name":"picomolar (pM)","can_manage":0,"read_only":0},{"id":32,"type_id":24,"name":"Room temperature","can_manage":0,"read_only":0},{"id":33,"type_id":30,"name":"rpm","can_manage":0,"read_only":0},{"id":34,"type_id":30,"name":"x g","can_manage":0,"read_only":0},{"id":165,"type_id":24,"name":"On ice","can_manage":0,"read_only":0},{"id":200,"type_id":32,"name":"cm","can_manage":0,"read_only":0},{"id":201,"type_id":32,"name":"mm","can_manage":0,"read_only":0},{"id":202,"type_id":32,"name":"µm","can_manage":0,"read_only":0},{"id":203,"type_id":32,"name":"nm","can_manage":0,"read_only":0},{"id":204,"type_id":25,"name":"mg/mL","can_manage":0,"read_only":0},{"id":205,"type_id":25,"name":"µg/µL","can_manage":0,"read_only":0},{"id":206,"type_id":25,"name":"% (v/v)","can_manage":0,"read_only":0},{"id":1324,"type_id":30,"name":"rcf","can_manage":0,"read_only":0},{"id":1359,"type_id":35,"name":"Bar","can_manage":0,"read_only":0},{"id":1360,"type_id":35,"name":"Pa","can_manage":0,"read_only":0}],"uri":"changes-in-bone-mineral-density-and-incidence-of-f-cwm6xc9e","url":"https://www.protocols.click/view/changes-in-bone-mineral-density-and-incidence-of-f-cwm6xc9e","version_class":84382,"version_data":{"id":0,"code":"cwm6xc9e","version_class":84382,"parent_id":null,"parent_uri":null,"is_same_owner":false,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":false,"merge_request":null},"version_id":0,"version_uri":"changes-in-bone-mineral-density-and-incidence-of-f-6qpvr3ombvmk/v1","versions":[{"id":84382,"title":"Changes in Bone Mineral Density and Incidence of Fractures during Two Years of Low Dose Glucocorticoid Treatment for Rheumatoid Arthritis: Protocol for a Systematic Review and Individual Participant Data Meta-Analysis","title_html":"Changes in Bone Mineral Density and Incidence of Fractures during Two Years of Low Dose Glucocorticoid Treatment for Rheumatoid Arthritis: Protocol for a Systematic Review and Individual Participant Data Meta-Analysis","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.6qpvr3ombvmk/v1","uri":"changes-in-bone-mineral-density-and-incidence-of-f-cwm6xc9e","published_on":1688372108,"modified_on":1688372108,"version_class":84382,"version_id":0,"version_code":"cwm6xc9e","version_uri":"changes-in-bone-mineral-density-and-incidence-of-f-6qpvr3ombvmk/v1","created_on":1688371221,"categories":null,"creator":{"name":"Andriko Palmowski","affiliation":"Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Germany","affiliation_url":"http://www.charite.de/","username":"andriko-palmowski","link":"","image":{"source":"/img/avatars/009.png","placeholder":"/img/avatars/009.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}}],"warning":""}